These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20922573)

  • 1. Functional polymorphisms associated with disease-free survival in resected carcinoma of the esophagus.
    Boonstra JJ; van Marion R; Tilanus HW; Dinjens WN
    J Gastrointest Surg; 2011 Jan; 15(1):48-56. PubMed ID: 20922573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma.
    Renouf DJ; Zhai R; Sun B; Xu W; Cheung WY; Heist RS; Kulke MH; Cescon D; Asomaning K; Marshall AL; Li S; Christiani DC; Liu G
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1482-8. PubMed ID: 23735059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection.
    Li J; Tang Y; Huang L; Yu Q; Hu G; Yuan X
    PLoS One; 2016; 11(7):e0158613. PubMed ID: 27414035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis.
    Cescon DW; Bradbury PA; Asomaning K; Hopkins J; Zhai R; Zhou W; Wang Z; Kulke M; Su L; Ma C; Xu W; Marshall AL; Heist RS; Wain JC; Lynch TJ; Christiani DC; Liu G
    Clin Cancer Res; 2009 May; 15(9):3103-9. PubMed ID: 19383811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
    Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
    BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2 -330T>G genetic polymorphism associates with prognosis following surgery for thoracic esophageal squamous cell cancer.
    Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Yoshino K; Nakatsu T; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2011 Jul; 18(7):1995-2002. PubMed ID: 21258967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
    Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
    World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome.
    Korpanty GJ; Eng L; Qiu X; Faluyi OO; Renouf DJ; Cheng D; Patel D; Chen Z; Tse BC; Knox JJ; Dodbiba L; Teichman J; Azad AK; Wong R; Darling G; Reisman D; Cuffe S; Liu G; Xu W
    Oncotarget; 2017 Apr; 8(17):28093-28100. PubMed ID: 28427211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival.
    Liu L; Wu C; Wang Y; Zhong R; Duan S; Wei S; Lin S; Zhang X; Tan W; Yu D; Nie S; Miao X; Lin D
    J Thorac Oncol; 2011 Nov; 6(11):1793-800. PubMed ID: 21841506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy.
    Zhou F; Zhu M; Wang M; Qiu L; Cheng L; Jia M; Xiang J; Wei Q
    J Transl Med; 2016 May; 14(1):154. PubMed ID: 27246611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas.
    Zhang XF; Wang YM; Ge H; Cao YY; Chen ZF; Wen DG; Guo W; Wang N; Li Y; Zhang JH
    Dis Esophagus; 2008; 21(1):21-9. PubMed ID: 18197935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 polymorphisms and susceptibility to esophageal cancer: a meta-analysis.
    Liang Y; Liu JL; Wu Y; Zhang ZY; Wu R
    Tohoku J Exp Med; 2011 Feb; 223(2):137-44. PubMed ID: 21304218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study.
    Wani S; Drahos J; Cook MB; Rastogi A; Bansal A; Yen R; Sharma P; Das A
    Gastrointest Endosc; 2014 Feb; 79(2):224-232.e1. PubMed ID: 24060519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection.
    Probst A; Aust D; Märkl B; Anthuber M; Messmann H
    Endoscopy; 2015 Feb; 47(2):113-21. PubMed ID: 25479563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
    Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
    Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
    Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
    Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
    Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
    Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.
    Sharaiha RZ; Halazun KJ; Mirza F; Port JL; Lee PC; Neugut AI; Altorki NK; Abrams JA
    Ann Surg Oncol; 2011 Nov; 18(12):3362-9. PubMed ID: 21547702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in the insulin-like growth factor axis are associated with gastrointestinal cancer.
    Ong J; Salomon J; te Morsche RH; Roelofs HM; Witteman BJ; Dura P; Lacko M; Peters WH
    PLoS One; 2014; 9(3):e90916. PubMed ID: 24608110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.